Wearable Devices and Biomarkers Project (Healthiomics)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCureScience
About this trial
The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
Participant is ≥ 18 years of age.
Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR
Disqualifiers
Participant or participant's legally authorized representative is unable to provide informed consent.
Trial population
Potential participants will be referred to the study by a medical provider. Participants may be of sex/gender, race, or ethnic background. Participants must have the capacity to consent, or have a legally authorized representative willing to consent.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
3,500 Participants
are grouped into 2 trial groupsGroup A: Neurological patients
Group B: Control
Trial outcomes
Primary outcomes
1
Specimen and data storage
To collect and store biological specimens (such as, but not limited to, tissue, blood, urine, cerebrospinal fluid, etc.), data from functional and anatomical imaging modalities, digital health data and clinical data from patients with cancer or neurological disorders, those who are under evaluation for a possible cancer or neurologic disorders, or healthy controls.
Time frame
4 yearsSecondary outcomes
1
Specimen and data analysis
To perform multi-modality analysis of specimens for biomarker discovery.
Time frame
4 years2
Collaboration
To make specimens and data available to collaborating investigators performing IRB-approved research of cancer or neurological disorders.
Time frame
4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov